6QW-12790-17019
2 vaccinations
10 coded responses
19 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 947 / CA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
- 2021-01-01
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Cold sweat — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Cold sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
- 2021-01-04
-
2021-01-05
Survey response — days 1–6 daily, dose 1MedDRA: Night sweats — Feeling: Good · ChillsFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Survey response — days 1–6 daily, dose 1MedDRA: Injection site lymphadenopathy, Injection site pain — Feeling: FairFree text: Painful swollen axillary lymph node proximal to injection site in left deltoidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Survey response — day 7, dose 1MedDRA: Lymphadenopathy, Tenderness — Feeling: GoodFree text: Proximal axillary lymphadenopathy and tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
-
2021-01-21
Survey response — day 21, dose 1MedDRA: Night sweats, Syncope — Feeling: Good · Be unable to workFree text: Unexplained syncopal episode on 1/19Near nightly cold night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — day 28, dose 1MedDRA: Dizziness, Syncope — Feeling: GoodFree text: Repeated dizziness and faintingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Dose 2 — Moderna
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Fatigue, Pain, Pyrexia — Feeling: Good · Fatigue or tirednessFree text: Fever up to 102.5, body aches, joint pain, and fatigue on 1/30. Was not contacted that day for vsafe check in on the day after my second shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-12
- 2021-03-05
- 2021-03-14
-
2021-05-02
Survey response — 3 months, dose 2MedDRA: Dizziness, Night sweats — Feeling: FairFree text: Intermittent dizziness/near fainting. Night -sweats.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Nausea, Night sweats — Feeling: FairFree text: Persistent night sweats and nauseaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-31
Survey response — 12 months, dose 2MedDRA: Blood prolactin increased, Blood thyroid stimulating hormone increased, Laboratory test abnormal, Menstruation irregular, Nausea, Vomiting — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Menstrual irregularities: new nausea and vomiting before period x 1 year, elevated prolactin, TSH, and E2MedDRA releases: 2024-11 · check-in free text available
-
2022-01-31
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-03
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Cold sweats
Systemic reaction (other): Night sweats
Systemic reaction (other): Painful swollen axillary lymph node proximal to injection site in left deltoid
Release 1 — day 7, dose 1
Systemic reaction (other): Proximal axillary lymphadenopathy and tenderness
Release 2 — day 21, dose 1
Symptoms: Unexplained syncopal episode on 1/19Near nightly cold night sweats
Release 2 — day 28, dose 1
Symptoms: Repeated dizziness and fainting
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Fever up to 102.5, body aches, joint pain, and fatigue on 1/30. Was not contacted that day for vsafe check in on the day after my second shot.
Release 8 — 3 months, dose 2
Symptoms: Intermittent dizziness/near fainting. Night -sweats.
Release 9 — 6 months, dose 2
Symptoms: Persistent night sweats and nausea
Release 11 — 12 months, dose 2
Symptoms: Menstrual irregularities: new nausea and vomiting before period x 1 year, elevated prolactin, TSH, and E2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood prolactin increased | · | · | ✓ |
| SD | Blood thyroid stimulating hormone increased | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release